in SUSTAIN 110, subcutaneous semaglutide was associated with a decrease in HbA 1c of 13.119.6 mmol/mol (1.21.8%) and a decrease in body weight of 4.56.5 kg [9, 21]
Exenatide is eliminated primarily through the kidneys, and its use is not recommended in patients with a creatinine clearance (CrCl) of 30 mL/min
By increasing GHRH and lowering somatostatin, GHRP-6 enhances the bodys natural growth hormone production, promoting muscle growth, fat burning, and tissue repair
It notes that its steady, once-daily action can help maintain focus throughout the day without the peaks and crashes some patients experience on shorter-acting stimulants
Hitting those targets helps prevent side effects like nausea and constipation while supporting steady weight loss
doi: 10.1096/fj.14-265355, 41